Computational techniques for enhancing PK/PD modeling and simulation and ADMET prediction
Authors:
- Shamsul GhaniSGShamsul Ghani
- Nasar KhanNKNasar Khan
- Harsh SableHSHarsh Sable
- Fen YaoFYFen Yao
- Muhammad ShafiqMSMuhammad Shafiq
- 23 July 2025
- book chapter
- Published by Elsevier
- p. 153-174
Abstract
No abstract availableThis publication has 47 references indexed in Scilit:
- Current State and Challenges of Physiologically Based Biopharmaceutics Modeling (PBBM) in Oral Drug Product DevelopmentPharmaceutical Research, 2022
- Opportunities and challenges for applying model‐informed drug development approaches to gene therapiesCPT: Pharmacometrics & Systems Pharmacology, 2021
- From Therapeutic Drug Monitoring to Model‐Informed Precision Dosing for AntibioticsClinical Pharmacology & Therapeutics, 2021
- Pharmacodynamic Drug–Drug InteractionsClinical Pharmacology & Therapeutics, 2019
- Good Practices in Model‐Informed Drug Discovery and Development: Practice, Application, and DocumentationCPT: Pharmacometrics & Systems Pharmacology, 2015
- Systems pharmacology modeling: an approach to improving drug safetyBiopharmaceutics & Drug Disposition, 2013
- Application of pharmacokinetics–pharmacodynamics/clinical response modeling and simulation for biologics drug developmentJournal of Pharmaceutical Sciences, 2012
- Pharmacokinetic/ Pharmacodynamic‐Driven Drug DevelopmentMount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine, 2010
- The role of population PK–PD modelling in paediatric clinical researchEuropean Journal of Clinical Pharmacology, 2010
- Pharmacometrics: modelling and simulation tools to improve decision making in clinical drug developmentEuropean Journal of Drug Metabolism and Pharmacokinetics, 2000